They found that the activation of Nrf2 in liver cells of PBC patients was enhanced after UDCA treatment and thioredoxin (TRX) and thioredoxin reductase 1 (TrxR1) protein significantly increased (Figure 5) (Kawata et al., 2010). This evidence concerns the gene TXNRD1 and primary biliary cholangitis.